COVID-19: Post-covid Olfactory Disorders Assessment

Centre Hospitalier Universitaire de Nice

Status: Completed

Conditions: Olfaction Disorders

Study type: Observational

Funder types: Other

Identifiers

NCT04799977

21IUFCcovid01

Details and patient eligibility

About

Covid 19 cause an olfactory loss in more than 80% of cases. This loss most often regresses but leaves 20% of patients with an olfactory complaint, particularly with regard to the quality of daily life. The neuro-cognitive implications involved with COVID19 and the consequences of persistent olfactory loss remain unknown. The effectiveness of therapeutic management, in particular olfactory re-education, has not yet been clarified. Objectives are the assessment of patients olfactory disorders, psychiatrics and neurocognitives specificities after a COVID, before and after treatment or specific cares.

Enrollment: 56 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults patient,
• anosmia during a COVID19 acute infection (PCR+) and persistant olfactive disoders at least 6 weeks after symptoms disappeared.

Exclusion criteria

• preexisting smell loss.

Trial design

56 participants in 2 patient groups

COVID19 infection with olfaction disorder

Description:

Patients, ≥18 ans, who suffered from an olfaction disorder while going through a COVID19 infection

COVID19 infection without olfaction disorder

Description:

Patients, ≥18 ans, who suffered from a COVID19 infection without any olfaction disorders